Literature DB >> 7729448

Induction of beta-lactamase by cefoxitin in anaerobic intestinal microflora.

C Stark1, C Edlund, M Hedberg, C E Nord.   

Abstract

Beta-lactamases produced by two anaerobic bacterial strains, Bacteroides ovatus Ax34:1 and Clostridium butyricum NBL3, were shown to be significantly inducible under anaerobic conditions in subinhibitory concentrations of cefoxitin. The induction ratio of beta-lactamase production for Bacteroides ovatus was 2.6 and for Clostridium butyricum 1.6. Incubation of faecal samples with different concentrations of cefoxitin did not result in any induction of beta-lactamase production. When adding a highly inducible aerobic strain (Citrobacter freundii F72:6, induction ratio of 26.5 in broth culture) to faecal samples, an induction ratio of 4.5 was reached. Faeces seem to inhibit beta-lactamase induction in aerobic and anaerobic bacteria. The inducible enzymes produced by the anaerobic strains did not have the same properties as beta-lactamases from aerobic inducible strains, according to substrate profiles and inhibition studies. The results of the present study indicate that increased levels of beta-lactamases in the normal intestinal microflora, which often are observed after administration of beta-lactam agents, are probably due to selection of stably derepressed mutants rather than to induction of beta-lactamase production.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7729448     DOI: 10.1007/bf02112613

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  21 in total

Review 1.  The crisis in antibiotic resistance.

Authors:  H C Neu
Journal:  Science       Date:  1992-08-21       Impact factor: 47.728

Review 2.  Classification of beta-lactamases: groups 1, 2a, 2b, and 2b'.

Authors:  K Bush
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

3.  Use of beta-lactamase-producing anaerobes to prevent ceftriaxone from degrading intestinal resistance to colonization.

Authors:  F Léonard; A Andremont; B Leclerq; R Labia; C Tancrède
Journal:  J Infect Dis       Date:  1989-08       Impact factor: 5.226

Review 4.  Clinical importance of inducible beta-lactamases in gram-negative bacteria.

Authors:  C C Sanders; W E Sanders
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

5.  The in vitro inactivation of thirteen beta-lactam antibiotics by other mechanisms than adsorption to faecal substance.

Authors:  H de Vries-Hospers; G Jansen; R Tonk; D Oenema; D van der Waaij
Journal:  Infection       Date:  1993 Mar-Apr       Impact factor: 3.553

6.  Ability of ceftibuten to induce the class-I beta-lactamases of Enterobacter cloacae, Serratia marcescens, and Enterobacter aerogenes.

Authors:  G A Papanicolaou; A A Medeiros
Journal:  Diagn Microbiol Infect Dis       Date:  1991 Jan-Feb       Impact factor: 2.803

7.  Purification and characterization of a new beta-lactamase from Clostridium butyricum.

Authors:  T Kesado; L Lindqvist; M Hedberg; K Tunér; C E Nord
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

8.  Clavulanate and beta-lactamase induction.

Authors:  D M Livermore; M Akova; P J Wu; Y J Yang
Journal:  J Antimicrob Chemother       Date:  1989-11       Impact factor: 5.790

Review 9.  Ecological impact of antimicrobial prophylaxis on intestinal microflora in patients undergoing colorectal surgery.

Authors:  B Brismar; C Edlund; A S Malmborg; C E Nord
Journal:  Scand J Infect Dis Suppl       Date:  1990

10.  Nonspecific induction of beta-lactamase in Enterobacter cloacae.

Authors:  W Cullmann; A Dalhoff; W Dick
Journal:  J Gen Microbiol       Date:  1984-07
View more
  3 in total

1.  Rationale behind high-dose amoxicillin therapy for acute otitis media due to penicillin-nonsusceptible pneumococci: support from in vitro pharmacodynamic studies.

Authors:  P D Lister; A Pong; S A Chartrand; C C Sanders
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

2.  Beta-lactamase production by oral anaerobic gram-negative species in infants in relation to previous antimicrobial therapy.

Authors:  S Nyfors; E Könönen; A Takala; H Jousimies-Somer
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

3.  Effects of treatment with antimicrobial agents on the human colonic microflora.

Authors:  Fatemeh Rafii; John B Sutherland; Carl E Cerniglia
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.